Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk's Wegovy, a high-dose version of its diabetes treatment Ozempic
Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C, et al
HSA/FSA Account A Health Savings Account is a special savings account that uses pre-tax money to pay for qualified medical expenses
Clinical evidence shows that Ozempic is associated with a small increase in resting heart rate typically in the range of 2-3 beats per minute on average, as documented in the Summary of Product Characteristics
Brain signaling: They bind to hypothalamus receptors, dialing down appetite signals by 3040%